Amneal Pharmaceuticals, Inc. ($AMRX)
Filing Information
| Accession Number | 0001628280-26-056754 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 13, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
216,613
Total Value
$3,771,050.10
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Legal Officer | Class A Common Stock | โ | Aug 11, 2026 | Sale | 6,613 | $17.70 | $117,050.10 | 245,171 | Direct | โ | View Details | |
EVP, Chief Legal Officer | Class A Common Stock | โ | Aug 12, 2026 | Sale | 210,000 | $17.40 | $3,654,000.00 | 35,171 | Direct | โ | View Details |